Humacyte HUMA
NASDAQ HUMA
$0.41 +0.01 (+1.28%)
At close: Oct 21, 2026 · 4:00 PM EDT

Humacyte (HUMA) Revenue (2020 - 2026)

Updated

Humacyte (HUMA) posted Revenue of $406,000 for Q2 2026, up 34.9% from $301,000 a year earlier but down 18.0% from the prior quarter.

Analysis

Humacyte (HUMA) Revenue (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Humacyte was $2.12 million, up 159.3% year-over-year; for FY2025, it came in at $2.04 million.

  • Quarterly Revenue has run from a low of $241,000 in Q3 2021 to a high of $753,000 in Q3 2025 over five years.
  • According to Business Quant data, Revenue for the three prior quarters was $495,000 (Q1 2026), $467,000 (Q4 2025) and $753,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.31 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 16.99 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 15.03 Bn
10 Humacyte 97.33 Mn -101.11 Mn -825,000.00 406,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 406,000.00
Mar 31, 2026 495,000.00
Dec 31, 2025 467,000.00
Sep 30, 2025 753,000.00
Jun 30, 2025 301,000.00
Mar 31, 2025 517,000.00
Sep 30, 2021 241,000.00
Sep 30, 2020 914,000.00
API Access

Humacyte Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=HUMA&period=max&api_key=YOUR_API_KEY